Yadira Bencosme

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

Stephen L. Hauser, Rob Knight, Sergio E. Baranzini, 2017, Proceedings of the National Academy of Sciences.

Association of Deep GrayMatter Damage With Cortical and Spinal Cord Degeneration in Primary ProgressiveMultiple Sclerosis

F. Lublin, M. Inglese, S. Ruggieri, 2015 .

Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.

F. Lublin, Aaron E Miller, M. Inglese, 2015, JAMA neurology.

Disease-modifying therapies alter gut microbial composition in MS

Justine W. Debelius, J. Clemente, R. Knight, 2018, Neurology: Neuroimmunology & Neuroinflammation.

Emergency Medical Care of Multiple Sclerosis Patients: Primary Data from the Mount Sinai Resource Utilization in Multiple Sclerosis Project

F. Lublin, S. Krieger, Yadira Bencosme, 2014, Journal of clinical neurology.

The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS (P2.205)

R. Knight, S. Mazmanian, S. Baranzini, 2015 .

Effect of oral versus injectable disease-modifying therapies on the epigenome-wide DNA methylation and gut microbiota in multiple sclerosis patients

Justine W. Debelius, R. Knight, S. Mazmanian, 2016 .